IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial
The shares of oncology-focused Ideaya Biosciences Inc (NASDAQ: IDYA) are trading higher after interim data from its solid tumor candidate darovasertib with cancer…
BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial
In an SEC filing, BioMarin Pharmaceutical Inc (NASDAQ:BMRN) said that, in August, a participant in its valoctocogene roxaparvovec (BMN 270)…
POINT Biopharma Shares Jump After Updated Efficacy, Safety Data From Prostate Cancer Candidate
POINT Biopharma Global Inc (NASDAQ:PNT) shared updated efficacy and safety data from the 27-patient lead-in cohort for the Company’s phase 3…
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on immunology therapeutics, has sold its royalty interest on future global…
Europe Approves Novavax’s COVID-19 Vaccine Booster For Adults
The European Commission has approved the expanded conditional approval of Novavax Inc’s (NASDAQ:NVAX) Nuvaxovid COVID-19 vaccine as a homologous and heterologous booster…
Regulus Shares Surge After Early-Stage RGLS8429 Data In Rare Kidney Disease
Biopharmaceutical company Regulus Therapeutics Inc (NASDAQ: RGLS) shares jumped after topline safety and Pharmacokinetic (PK) data from its Phase 1 single-ascending dose (SAD) trial of RGLS8429 in autosomal dominant polycystic kidney disease (ADPKD).
Novartis’ Cosentyx Shows To Ease Symptoms In Painful Skin Condition
Novartis AG (NYSE:NVS) announced the results from two Phase 3 studies (SUNSHINE and SUNRISE) of Cosentyx (secukinumab) in moderate-to-severe hidradenitis suppurativa…
Cardiff Oncology Shares Pop After Lead Asset In KRAS-Mutated Colorectal Cancer
Clinical-stage biotech Cardiff Oncology Inc (NASDAQ:CRDF) announced new preclinical and clinical data from its lead program in KRAS-mutated metastatic colorectal carcinoma (mCRC)…
BeiGene’s Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors
BeiGene Limited (NASDAQ:BGNE) shared updates from its solid tumor development program for tislelizumab at the European Society for Medical Oncology (ESMO)…
Ra Medical Systems Announces Reverse Merger; Combined Company To Focus On Cardiac Arrhythmias
Ra Medical Systems Inc (NYSE:RMED) has agreed to merge with privately held Catheter Precision Inc, a medical device and technology company focused…